BioSpace News Archive

Business

Veracyte Announces First Quarter 2020 Financial Results

Veracyte, Inc. announced financial results for the first quarter ended March 31, 2020 and provided an update on recent business progress.

May 6, 2020
·
8 min read
Business

QIAGEN Reports Full Results for First Quarter of 2020

QIAGEN N.V. (NYSE:QGEN; Frankfurt Prime Standard:QIA) announced full results of operations for the first quarter of 2020, with net sales and adjusted earnings per share (EPS) in line with the preliminary results announced on April 9, 2020.

May 6, 2020
·
2 min read
Business

Bruker Reports First Quarter 2020 Financial Results

Bruker Corporation announced financial results for its first quarter ended March 31, 2020.

May 6, 2020
·
9 min read
Biotech Bay

Exelixis to Webcast Fireside Chats as Part of Virtual Investor Conferences in May

Exelixis, Inc. (Nasdaq: EXEL) today announced that members of Exelixis’ management team will participate in fireside chats at the following virtual investor conferences in May:

May 6, 2020
·
2 min read
Business

Misonix to Report Fiscal 2020 Third Quarter Financial Results and Host Conference Call and Webcast on May 11

Misonix, Inc., a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, announced that it will report its fiscal 2020 third quarter financial results after the market closes on Monday, May 11, 2020.

May 6, 2020
·
1 min read
Biotech Bay

LakePharma Supplying Mount Sinai with SARS-CoV-2 Proteins for Serological Assays

LakePharma announces that the company will be supplying the Mount Sinai Health System recombinant SARS-CoV-2 spike proteins to the Mount Sinai Laboratory as a component in its blood test for antibody response against SARS-CoV-2, the virus that causes the COVID-19 pandemic.

May 6, 2020
·
3 min read
FDA

Foundation Medicine Receives FDA Approval for FoundationOne®CDx as the Companion Diagnostic for Tabrecta™ (capmatinib), the Only FDA-Approved MET Inhibitor for Patients With Metastatic Non-Small Cell Lung Cancer With METex14

Foundation Medicine, Inc. announced that FoundationOne®CDx has been approved by the U.S. Food and Drug Administration for use as the companion diagnostic to aid in identifying patients with non-small cell lung cancer for whom treatment with Tabrecta™ may be appropriate.

May 6, 2020
·
4 min read
BioMidwest

Foundation for Sarcoidosis Research and University of Cincinnati Share Initial Results of COVID-19 Impact Survey

COVID-19 has changed our world. As of April 27, 2020, the Johns Hopkins University Coronavirus Resource Center reported over 3 million cases of COVID-19 worldwide, including 979,077 in the United States.

May 6, 2020
·
2 min read
Biotech Bay

Guardant Health to Participate in the BofA Securities 2020 Healthcare Conference

Guardant Health, Inc. announced the company will be participating in the upcoming BofA Securities Virtual Healthcare Conference.

May 6, 2020
·
1 min read
Business

G1 Therapeutics Provides First Quarter 2020 Corporate and Financial Update

G1 Therapeutics, Inc., a clinical-stage oncology company, provided a corporate and financial update for the first quarter ended March 31, 2020.

May 6, 2020
·
9 min read